Biophytis SA (BPTSY)
4.88
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Biophytis Research and Development Expense (Annual): 9.576M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.576M |
| December 31, 2022 | 16.91M |
| December 31, 2021 | 23.27M |
| December 31, 2020 | 11.33M |
| December 31, 2019 | 10.18M |
| December 31, 2018 | 11.23M |
| Date | Value |
|---|---|
| December 31, 2017 | 7.976M |
| December 31, 2016 | 5.668M |
| December 31, 2015 | 2.185M |
| December 31, 2014 | 0.965M |
| December 31, 2013 | 0.9157M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
9.576M
Minimum
2023
23.27M
Maximum
2021
14.25M
Average
11.33M
Median
2020
Research and Development Expense (Annual) Benchmarks
| DBV Technologies SA | 60.22M |
| Cellectis SA | 87.65M |
| Genfit SA | 50.57M |
| Innate Pharma SA | 60.65M |
| Inventiva SA | 119.10M |